State-of-the-art basic and clinical science of Kawasaki disease. The 9th International Kawasaki Disease Symposium 10-12 April 2008, Taipei, Taiwan
Journal
Pediatric Health
Journal Volume
2
Journal Issue
4
Pages
405-409
Date Issued
2008
Author(s)
SDGs
Other Subjects
acetylsalicylic acid; anticoagulant agent; antiinflammatory agent; antithrombin; antithrombocytic agent; biological marker; corticosteroid; etanercept; hydroxymethylglutaryl coenzyme A reductase inhibitor; immunoglobulin; infliximab; low molecular weight heparin; toll like receptor; transcription factor NFAT; tumor necrosis factor alpha; tumor necrosis factor alpha inhibitor; warfarin; adaptive immunity; aneurysm; arterial wall thickness; arteriosclerosis; atherosclerosis; cardiovascular risk; child care; clinical effectiveness; clinical trial; cluster analysis; conference paper; coronary artery aneurysm; coronary artery bypass graft; counseling; disease model; drug dose reduction; drug efficacy; drug response; drug safety; drug substitution; drug withdrawal; echography; gene expression; genetic association; genetic susceptibility; genetic variability; geographic distribution; health survey; hepatomegaly; human; immunopathogenesis; incidence; innate immunity; intermethod comparison; international cooperation; long term care; medical research; monotherapy; mucocutaneous lymph node syndrome; nonhuman; nuclear magnetic resonance imaging; patient identification; percutaneous coronary intervention; persistent infection; prognosis; protein function; risk assessment; risk factor; seasonal variation; single nucleotide polymorphism; surgical technique; symposium; T lymphocyte; Taiwan
Type
conference paper